Literature DB >> 3059678

The location, sequence, transcription, and regulation of a baculovirus DNA polymerase gene.

M D Tomalski1, J G Wu, L K Miller.   

Abstract

The Autographa californica nuclear polyhedrosis virus (AcMNPV) DNA polymerase gene was identified with the aid of an oligonucleotide probe corresponding to an amino acid sequence conserved among viral DNA polymerases of other virus families. A 3.6-kb pair region of the AcMNPV DNA, from 39.5 to 42.5 map units (m.u.), was sequenced and an open reading frame (ORF) of 2994 bp was observed. From the first ATG of this ORF, a translation product of 984 amino acids (Mr 114,310) was predicted. Amino acid sequence similarities to other viral DNA polymerases were found. Transcription was analyzed by Northern RNA blot analysis and nuclease protection studies of RNA:DNA hybrids. The ORF is transcribed in the counterclockwise direction as a 3-kb RNA. Transcripts appear to initiate at two differently regulated sites (ca. -120 and -212 bp) upstream of the initiating ATG (+1,+2,+3) and to be polyadenylated at a single site near a signal (A2UA3) which overlaps the translational termination signal (UAA) at +2952. Transcripts were observed only during a narrow window between 2 to 8 hr postinfection (p.i.) with maximum expression between 4 and 6 hr p.i. Polymerase gene transcripts were observed in the presence of the protein synthesis inhibitor cycloheximide which also blocked the shut-off of these early transcripts. Aphidicolin, an inhibitor of both viral and host DNA polymerases, inhibited polymerase gene transcription suggesting a unique regulation involving DNA replication.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3059678

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  62 in total

1.  Baculovirus replication factor LEF-1 is a DNA primase.

Authors:  Victor S Mikhailov; George F Rohrmann
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Autographa californica nucleopolyhedrovirus orf69 encodes an RNA cap (nucleoside-2'-O)-methyltransferase.

Authors:  Xiaofeng Wu; Linda A Guarino
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  Genetic requirements for homologous recombination in Autographa californica nucleopolyhedrovirus.

Authors:  Erin A Crouch; A Lorena Passarelli
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

4.  Functional dissection of the Autographa californica nuclear polyhedrosis virus immediate-early 1 transcriptional regulatory protein.

Authors:  G R Kovacs; J Choi; L A Guarino; M D Summers
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.

Authors:  C B Hwang; K L Ruffner; D M Coen
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

6.  In vitro transactivation of baculovirus early genes by nuclear extracts from Autographa californica nuclear polyhedrosis virus-infected Spodoptera frugiperda cells.

Authors:  B Glocker; R R Hoopes; G F Rohrmann
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  Replication patterns and cytopathology of cells infected with baculoviruses.

Authors:  G V Williams; P Faulkner
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

8.  Regulation of expression of a baculovirus ecdysteroid UDPglucosyltransferase gene.

Authors:  D R O'Reilly; L K Miller
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

9.  Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.

Authors:  J D Hall; Y S Wang; J Pierpont; M S Berlin; S E Rundlett; S Woodward
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

10.  Selection and characterization of Autographa californica multiple nucleopolyhedrovirus DNA polymerase mutations.

Authors:  Guozhong Feng; David K Thumbi; Jondavid de Jong; Jeffrey J Hodgson; Basil M Arif; Daniel Doucet; Peter J Krell
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.